David Watson, MD
Orthopaedic Surgery · Temple Terrace, FLNPI 1992779474
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 79.2% of it on its own, with 25 other manufacturers making up the rest. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $679.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$109K
- Si-bone, Inc.$14K
- F. Hoffmann-la Roche AG$11K
- Polynovo North America LLC$1K
- Zimmer Biomet$274
- Innovation Technologies Inc$249
- plus $2K from 20 others
Across 388 payments — averaging $53,798 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$20.7M
- Smith+Nephew$79K
- Takeda Pharmaceuticals U.S.A., Inc.$53K
- Omnilife Science, Inc$18K
- Corin USA$6K
- Eli Lilly$450
- plus $89 from 1 others
What the payments were for
- Consulting fees$50,80937%
- Speaking & faculty fees$71,63552%
- Travel & lodging$6,5055%
- Food & beverage$8,9406%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 116 | $109,216 |
| Si-bone, Inc. | 5 | $14,401 |
| F. Hoffmann-la Roche AG | 9 | $10,679 |
| Polynovo North America LLC | 28 | $1,262 |
| Zimmer Biomet | 4 | $274 |
| Innovation Technologies Inc | 2 | $249 |
| Painteq LLC | 1 | $175 |
| Johnson & Johnson(2 entities) | 4 | $165 |
| E.r. Squibb & Sons, L.L.C. | 2 | $164 |
| Zynex Medical, Inc. | 1 | $156 |
| Stryker(2 entities) | 5 | $146 |
| Peter Brasseler Holdings, LLC | 1 | $128 |
| Acell, Inc. | 2 | $125 |
| Acumed LLC | 1 | $120 |
| Sanara Medtech Inc. | 4 | $90 |
| Onkos Surgical, Inc. | 1 | $89 |
| Bioventus LLC | 5 | $85 |
| Coastal Medical Technologies LLC | 2 | $61 |
| Acera Surgical, Inc. | 1 | $58 |
| AbbVie | 1 | $56 |
| Amgen | 2 | $48 |
| Next Science LLC | 1 | $43 |
| MVP Orthopedics Inc | 2 | $30 |
| KCI USA, Inc. | 1 | $27 |
| Dynasplint Systems Inc. | 1 | $24 |
| Medtronic | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$66,488
- EVOS$38,396
- POLARCUP$28,913
- REAL INTELLIGENCE$26,062
- Oxinium Hips$25,088
- REDAPT$18,508
- Navio Surgical System$15,859
- POLARSTEM$15,387
- TRIGEN InterTAN$15,300
- EVOS MINI$15,300
- Anthology$14,228
- iFuse Implant$14,000
- Tandem$13,388
- Journey II XR$13,353
- R3$12,713
- Birmingham Hip Resurfacing$11,700
- RI.HIP NAVIGATION$10,688
- Journey II BCS$9,368
- Journey II CR$6,188
- TRIGEN$5,400
How this compares
$137,889 in reported general payments places this provider in the 90th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 139 | $4,096 |
| Ondansetron OdtOndansetron | 172 | $2,169 |
| Gabapentin | 183 | $1,580 |
| Meloxicam | 285 | $1,488 |
| Diclofenac Sodium | 57 | $1,203 |
| Mupirocin | 173 | $1,051 |
| Naloxone Hcl | 13 | $945 |
| Oxycodone Hcl | 147 | $849 |
| Tramadol Hcl | 234 | $739 |
| Methylprednisolone | 58 | $378 |
| Dexamethasone Sodium Phosphate | 12 | $376 |
| Naproxen | 15 | $186 |
| Amoxicillin | 141 | $168 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $166 |
| Omeprazole | 13 | $84 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Temple Terrace
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- Thomas BernasekTemple Terrace$6.4M
- Kenneth GustkeTemple Terrace$5.2M
- Mark MighellTemple Terrace$4.3M
- Michael GarciaTemple Terrace$1.1M
- Christopher BakerTemple Terrace$575K
- John SmallTemple Terrace$467K
- Brian PalumboTemple Terrace$414K
- Andrew CooperClearwater$102M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.